In8bio Inc (INAB) — Financial Flexibility Index

Latest as of March 2026: -1.42x

In8bio Inc (INAB) has a Financial Flexibility Index of -1.42x as of March 2026. Free cash flow of $-4.94 Million (operating CF $-4.95 Million minus capex $9.00K) represents -1% of total liabilities ($3.48 Million). Check In8bio Inc (INAB) strategic investment index to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-1.42x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-4.94 Million
Operating CF − Capex

Total Liabilities

$3.48 Million
USD

Capital Expenditures

$9.00K
USD

In8bio Inc Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for In8bio Inc across 8 annual periods. See In8bio Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for In8bio Inc (2018–2025)

Year-by-year free cash flow to debt coverage for In8bio Inc. For the full company profile including market capitalisation, see INAB company net worth.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -2.69x $-12.71 Million $-12.71 Million $4.72 Million ▲ +27.6%
2024 -3.72x $-24.05 Million $-24.15 Million $6.47 Million ▼ -43.4%
2023 -2.59x $-22.74 Million $-23.34 Million $8.77 Million ▼ -30.9%
2022 -1.98x $-20.42 Million $-24.12 Million $10.31 Million ▲ +39.4%
2021 -3.27x $-13.20 Million $-13.51 Million $4.04 Million ▼ -24.0%
2020 -2.64x $-6.82 Million $-7.13 Million $2.59 Million ▲ +13.0%
2019 -3.03x $-4.47 Million $-4.80 Million $1.48 Million ▼ -87.9%
2018 -1.61x $-2.01 Million $-2.77 Million $1.25 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities